Skip to main content

Find Clinical Trials

Home
Conditions
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma

Clinical trial condition

Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma

Explore clinical trials studying Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma trial results

Completed

Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery

NCT02538510

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +32 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details